Skip to main content
mBio logoLink to mBio
. 2021 Jun 15;12(3):e01132-21. doi: 10.1128/mBio.01132-21

Deacylated tRNA Accumulation Is a Trigger for Bacterial Antibiotic Persistence Independent of the Stringent Response

Whitney N Wood a,*, Kyle Mohler b,c, Jesse Rinehart b,c, Michael Ibba a,d,
Editor: Houra Merrikhe
PMCID: PMC8262941  PMID: 34126764

ABSTRACT

Bacterial antibiotic persistence occurs when bacteria are treated with an antibiotic and the majority of the population rapidly dies off, but a small subpopulation enters into a dormant, persistent state and evades death. Diverse pathways leading to nucleoside triphosphate (NTP) depletion and restricted translation have been implicated in persistence, suggesting alternative redundant routes may exist to initiate persister formation. To investigate the molecular mechanism of one such pathway, functional variants of an essential component of translation (phenylalanyl-tRNA synthetase [PheRS]) were used to study the effects of quality control on antibiotic persistence. Upon amino acid limitation, elevated PheRS quality control led to significant decreases in aminoacylated tRNAPhe accumulation and increased antibiotic persistence. This increase in antibiotic persistence was most pronounced (65-fold higher) when the relA-encoded tRNA-dependent stringent response was inactivated. The increase in persistence with elevated quality control correlated with ∼2-fold increases in the levels of the RNase MazF and the NTPase MazG and a 3-fold reduction in cellular NTP pools. These data reveal a mechanism for persister formation independent of the stringent response where reduced translation capacity, as indicated by reduced levels of aminoacylated tRNA, is accompanied by active reduction of cellular NTP pools which in turn triggers antibiotic persistence.

KEYWORDS: persistence, tRNA, translation

INTRODUCTION

Bacterial persisters are a subpopulation of dormant microbial cells that are not actively growing or dividing, which causes them to be tolerant to bactericidal antibiotics (1). Once the antibiotic reaches a low-enough concentration, persisters are able to resuscitate and the bacterial population resumes growth, leading to infection relapse and chronic bacterial infections (2). This mechanism of antibiotic-induced persisters is an example of triggered persistence, one of two different types of bacterial persistence. Different triggers that can cause bacterial cells to enter into a persistent state include antibiotics, amino acid starvation, immune factors, and other physiological stressors. Another type of persistence is spontaneous, which occurs when a subpopulation of bacteria becomes dormant while the vast majority of the bacterial culture are in the exponential phase of growth (3). Persistence can be characterized by the observation that the majority of a bacterial culture will be rapidly killed by exposure to an antibiotic while the subpopulation of persisters will have a much lower rate of killing. These different responses to antibiotics by the persistent and nonpersistent cells result in a biphasic killing curve that can be quantified by the minimum duration of killing (4). Antibiotic persistence differs from both resistance and tolerance. Antibiotic resistance is when bacteria are able to actively grow in the presence of antibiotics demonstrated by their elevated MIC for that antibiotic. Although antibiotic tolerance is similar to antibiotic persistence, the main difference is that tolerance affects the entire population resulting in a lower killing rate than with nontolerant bacteria but without any accompanying change in MIC (3, 4).

The health risk that persisters pose has caused them to receive considerable attention; however, the mechanisms underlying how persisters form remain elusive (5). Since persisters make up a small subpopulation of cells that have low biochemical activity, studying them presents challenges. Much of our current understanding of persisters comes from selection of high-persister mutants, those that display elevated levels of antibiotic tolerance, and from screenings for persistence using knockout libraries and transcriptome analyses (69). Several genes have been identified that might contribute to the dormant persister phenotype, many of which are members of toxin/antitoxin (TA) module systems. These modules are comprised of a stable toxin protein that when bound to the antitoxin forms an inactive complex; in the absence of the antitoxin, critical cellular functions such as protein translation or DNA replication are inhibited and cell growth is halted (1). One pathway to persister formation, via a TA module, involves the alarmone ppGpp. Several different external stressors can induce the synthesis of ppGpp, which activates Lon protease. The Lon protease degrades the antitoxin leading to inhibition of translation, slowing down cellular growth and increasing antibiotic tolerance (10, 11). However, this model for persister formation has recently been challenged, when it was shown that persister formation still occurs in an Escherichia coli ΔrelA ΔspoT background that is unable to synthesize ppGpp (12, 13). Additionally, another study has recently questioned the role of TA modules in persister formation (14). This new model proposes that a drop in intracellular ATP concentration acts as a trigger for persistence. This hypothesis proposes that a low concentration of ATP in the cell leads to a decrease in the activities of key antibiotic targets such as protein synthesis, DNA replication, cell wall biosynthesis, etc., leading to persistence (9, 12, 15). These results suggest that there is not a single route to persister formation; rather, there may exist several redundant pathways, all of which can lead to persistence. However, the identities of these pathways, their roles, and their possible connections to each other remain largely unclear.

Recently, several studies showed that perturbations in the protein synthesis machinery have effects on bacterial persistence (1622). Two of these studies involved the toxin HipA, which can phosphorylate glutamyl-tRNA synthetase (GluRS), thereby inactivating it. Aminoacyl-tRNA synthetases (aaRS) esterify amino acids to their cognate tRNA, and the resulting aminoacyl-tRNA (aa-tRNA) forms a ternary complex with EF-Tu and GTP which is then used as a substrate for ribosomal protein synthesis (23). When GluRS is inactivated by HipA, it is unable to synthesize Glu-tRNAGlu, and the intracellular concentration of deacylated tRNAGlu increases. Deacylated tRNAGlu directly enters the A-site of the ribosome which triggers the activation of RelA, a ppGpp synthase, and the stringent response is turned on, which causes RelA-dependent bacterial persistence (16). It was recently shown that HipA can also phosphorylate TrpRS and LysRS in addition to GluRS (21). Mutations in the genes encoding IleRS, LeuRS, ProRS, and MetRS have also been found that caused an increase in bacterial persistence. These mutations were identified in a ΔTA11 Escherichia coli strain, which has all 10 type II TA modules and the hipBA locus deleted, indicating that these persisters form via a different molecular mechanism than the one described previously where a toxin led to translation inhibition (19). Antibiotics that target TrpRS and LeuRS have also been used to study persistence in Chlamydia, which does not have the genes that encode RelA or SpoT and so does not appear to utilize the stringent response (20, 24). The Chlamydia persisters form by a molecular mechanism similar to the one described previously in which their trigger for persistence seems to be a direct effect from slowing down translation via accumulation of deacylated tRNA but independent of the stringent response.

Several studies have shown that the accuracy and efficiency of aminoacyl-tRNA synthesis are critical determinants of bacterial homeostasis (2527). To investigate how this global role of aaRSs might impact persistence, mutations in pheS and pheT, which encode the α-subunit and β-subunits of PheRS, respectively, were investigated in both E. coli MG1655 relA+ and ΔrelA backgrounds. Changes were made in both the active site and editing sites of PheRS to investigate the effects of varying aminoacylation efficiency and accuracy, respectively. The PheRS editing site is used to clear misacylated Tyr-tRNAPhe and m-Tyr-tRNAPhe. m-Tyr is a product of Phe oxidation and, in the absence of PheRS editing, has been shown to be mistranslated, causing cytotoxicity and other growth defects in E. coli (28, 29). PheRS quality control is also important beyond its primary role in maintaining translation accuracy, as demonstrated by the finding that when m-Tyr-tRNAPhe is not hydrolyzed by PheRS, the stringent response is suppressed (25). Changes in the active site of PheRS led to a significant decrease in the amount of aminoacylated tRNAPhe in response to amino acid stress, and this also resulted in a significant increase in antibiotic persistence but only in the strain that is unable to mount the stringent response. These data indicate that disruption of bacterial homeostasis via both reduced translation quality control and suppression of the stringent response together increases antibiotic persistence.

RESULTS

Changes in the active site of PheRS perturb discrimination against noncognate amino acids.

It has been previously shown that an editing-deficient PheRS E. coli variant, pheT G318W, had significant effects on cellular homeostasis under oxidative and amino acid stress (25, 29). This strain is not able to edit Tyr-tRNAPhe or m-Tyr-tRNAPhe, and consequently m-Tyr, a nonproteogenic amino acid, was shown to be incorporated into the proteome and cause cytotoxicity (28, 29). This PheRS editing-deficient strain was also shown to not activate the stringent response upon amino acid stress by m-Tyr addition (25). Taken together, these previous findings provided a basis to investigate the effects of PheRS quality control on bacterial antibiotic persistence and its dependence on the stringent response.

Along with an E. coli PheRS editing-deficient strain, additional E. coli mutant strains were made which chromosomally encode PheRS active site variants in both MG1655 relA+ and ΔrelA backgrounds (2931). The two active site mutations that were made on the E. coli chromosome encode the A294G and A294S variants in the α-subunit of PheRS. The A294G replacement in the active site of PheRS is predicted to have reduced amino acid substrate discrimination while the A294S replacement is predicted to have increased discrimination (32). These replacements were also made in recombinant E. coli PheRS to allow determination of the amino acid activation kinetics for the PheRS active site variants (Table 1). The specificity of Phe-to-m-Tyr for wild-type (WT) PheRS is 22, and for αA294G PheRS, it is 1.8, confirming that editing is required to prevent misacylated m-Tyr-tRNAPhe accumulation and that αA294G PheRS can only minimally discriminate between Phe and m-Tyr. In contrast, the specificity of Phe-to-m-Tyr for αA294S PheRS is 370, indicating that this mutant is not able to efficiently activate m-Tyr for aminoacylation. The same trend follows for the specificity of Phe-to-Tyr: αA294G PheRS has a reduced substrate specificity compared to wild-type PheRS, and αA294S PheRS has an increased specificity.

TABLE 1.

Steady-state kinetics of amino acid activation by E. coli wild-type PheRS and two active site PheRS mutants

PheRS Phe
m-Tyr
Tyra
Specificity
Km (μM) kcat (s−1) kcat/Km (s−1/μM) Km (μM) kcat (s−1) kcat/Km (s−1/μM) kcat/Km (s−1/μM) Phe/m-Tyr Phe/Tyr
WT 21 ± 1 61 ± 11 2.9 175 ± 31 23 ± 3 0.13 0.002 ± 0.0004 22 1,400
αA294G 59 ± 29 58 ± 16 1.0 62 ± 7 36 ± 6 0.6 0.01 ± 0.006 1.8 110
αA294S 27 ± 7 97 ± 10 3.6 NDa NDa 0.01 ± 0.003 0.001 ± 0.0002 370 3,700
a

Individual kinetic parameters could not be determined due to a high Km and substrate solubility. kcat/Km was estimated by ν = kcat/Km ([E][S]). Standard deviation is from 3 replicates. ND, not determined.

Bacterial antibiotic persistence increases when quality control is present, and the stringent response is disrupted.

To investigate if differences in noncognate substrate discrimination by PheRS variants affect antibiotic persistence, minimum duration of killing (MDK) assays were performed in both MG1655 relA+ and ΔrelA E. coli backgrounds (see Fig. S1 in the supplemental material). The four different PheRS strains (wild-type pheS/pheT, pheT G318W, pheS A294G, and pheS A294S) in both backgrounds were grown to early log phase and then treated with 100 μg/ml ampicillin for 3 h; each hour, an aliquot was taken out, washed with sterile phosphate-buffered saline (PBS), plated on LB plates, and incubated at 37°C overnight to calculate CFU. These assays were performed in two different types of media. The first, medium A, is the control medium which is a supplemented M9-based minimal medium that contains 40 μg/ml of all 20 proteogenic amino acids. The second, medium B, is the starvation medium which is also a supplemented M9-based minimal medium that contains 40 μg/ml of 18 proteogenic amino acids, 10 μg/ml Tyr, 40 μg/ml m-Tyr, and no Phe. The total amounts of persisters for wild-type PheRS, editing-deficient PheRS, and the two different active site PheRS mutant strains in both E. coli backgrounds were calculated at the endpoint after 3 h of exposure to ampicillin (Fig. 1). There was a significant increase in persisters for pheS A294S in the ΔrelA background grown in medium B compared to all the other PheRS strains that were tested. Three different variables were tested in this assay: relA either present or knocked out, different pheT and pheS mutations, and nutrient limitations. Each of the variables had an independent effect on persistence. For example, the deletion of relA caused an increase in persistence when the other two variables remained constant (compare solid blue bar and striped blue bar in WT pheS/pheT data set in Fig. 1). When the three different variables are combined, deletion of relA, PheRS quality control, and amino acid starvation, the effect on persistence is compounded and the largest amount of persister cell formation is observed. These data indicate that this pathway for bacterial antibiotic persistence is independent of the RelA-dependent stringent response.

FIG 1.

FIG 1

Antibiotic persistence increases when quality control is present, and the stringent response is disrupted. Persistence assays were done with wild-type pheS/pheT, pheT G318W, pheS A294G, and pheS A294S in both E. coli MG1655 relA+ (solid bars) and a XΔrelA -36292-8262-3643 strain (striped bars). Persistence was measured and quantified after 3 h of exposure to 100 μg/ml ampicillin and is shown on a log scale set relative to wild-type pheS/pheT in the relA+ background grown in medium A. Medium A (blue) is a supplemented M9 minimal medium that contains 40 μg/ml of all 20 proteogenic amino acids, and medium B (green) is a supplemented M9 minimal medium with 40 μg/ml of 18 proteogenic amino acids, 10 μg/ml Tyr, 40 μg/ml m-Tyr, and no Phe. Error bars represent standard deviations from 3 biological replicates. WT pheS/pheT relA+ in medium A and medium B is significant to pheS A294G ΔrelA in medium B with a P value of <0.03. All data sets are significant to pheS A294S ΔrelA in medium B with a P value of <0.0001, except for pheS A294G ΔrelA in medium B with a P value of 0.0008. Statistical analysis was performed using two-way analysis of variance (ANOVA).

FIG S1

Minimum duration of killing (MDK) assays for different E. coli PheRS strains in both a relA+ and ΔrelA background. Cultures were grown to early log phase and then exposed to 100 μg/ml ampicillin for 3 h. Cultures were taken out every hour, washed in sterile PBS, and plated to calculate CFU. (A) WT pheS/pheT; (B) editing-deficient PheRS, pheT G318W; (C) active site mutant PheRS, pheS A294G; (D) active site mutant pheS A294S. In each panel, MDK assay was performed in relA+ E. coli (black lines), ΔrelA E. coli (colored lines), medium A (solid lines), and medium B (dashed lines). Medium A is a supplemented M9 minimal medium that contains 40 μg/ml of all 20 proteogenic amino acids, and medium B is a supplemented M9 minimal medium with 40 μg/ml of 18 proteogenic amino acids, 10 μg/ml Tyr, 40 μg/ml m-Tyr, and no Phe. Error bars represent standard deviation from 3 biological replicates. Download FIG S1, PDF file, 0.1 MB (92KB, pdf) .

Copyright © 2021 Wood et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

A pheT G318W/pheS A294G double mutant was made in both the E. coli MG1655 relA+ and ΔrelA backgrounds. These strains would be able to synthesize, but not edit, m-Tyr-tRNAPhe and Tyr-tRNAPhe and therefore would generate high levels of misacylated tRNAPhe in the cell. The pheT G318W/pheS A294G double mutation allowed normal growth compared to the wild-type PheRS in medium A in both the relA+ and ΔrelA backgrounds. However, we were not able to perform persister assays on the pheT G318W/pheS A294G/ΔrelA mutant because the cells showed a substantial growth defect in medium B (Fig. S2).

FIG S2

Growth curves comparing wild-type PheRS and double mutant pheT G318W/pheS A294G in both a relA+ and ΔrelA background. Cultures were growing in either medium A or medium B, and OD600 was taken every hour for 8 h. Growth curves were performed with MG1655 E. coli relA+ with wild-type PheRS (solid line) and double mutant PheRS, pheS A294G/pheT G318W (dashed lines), in either medium A (green) or medium B (blue) or with ΔrelA E. coli with wild-type PheRS (solid line) and double mutant PheRS (dashed lines) in either medium A (purple) or medium B (orange). Medium A is a supplemented M9 minimal medium that contains 40 μg/ml of all 20 proteogenic amino acids, and medium B is a supplemented M9 minimal medium with 40 μg/ml of 18 proteogenic amino acids, 10 μg/ml Tyr, 40 μg/ml m-Tyr, and no Phe. Error bars represent standard deviation from 3 biological replicates. Download FIG S2, PDF file, 0.1 MB (81.9KB, pdf) .

Copyright © 2021 Wood et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

Levels of deacylated tRNAPhe correlate with the levels of persisters for the active site mutants of PheRS.

To investigate if there is a correlation between the levels of persistence and the levels of deacylated tRNAPhe, assays were performed to quantify tRNAPhe aminoacylation in all four PheRS strains in both relA+ and ΔrelA E. coli backgrounds grown in either medium A or medium B (Fig. 2). A representative Northern blot that was probed with a 32P-5′-end-labeled oligonucleotide that is specific for tRNAPhe is shown (Fig. 2A), and quantification from biological triplicates was performed (Fig. 2B). Overall, there was no difference in the levels of aminoacylated-tRNAPhe across all 4 different PheRS strains in the relA+ background grown in either medium A or medium B. The only instances in which significantly decreased levels of aminoacylated-tRNAPhe were observed were for the ΔrelA pheS A294G and ΔrelA pheS A294S mutant strains grown in medium B, the same conditions that also gave rise to the highest observed levels of persistence in this study.

FIG 2.

FIG 2

Levels of aminoacylated tRNAPhe correlate with antibiotic persistence. (A) Representative Northern blots with a 32P-5′-end-labeled tRNAPhe probe in which 10 μg total tRNA was separated by aminoacylated and deacylated tRNA species on an acid urea gel. For each strain, the left lane was grown in medium A and the right lane was grown in medium B. Left panel is tRNA purified from the E. coli MG1655 relA+ strain, and right panel is tRNA purified from the E. coli ΔrelA strain. (B) Percent aminoacylated tRNAPhe levels in vivo in wild-type pheS/pheT, pheT G318W, pheS A294G, and pheS A294S in both the relA+ strain (left panel) and a ΔrelA strain (right panel). Cultures were grown to late log phase in either medium A (solid bars), which is a supplemented M9 minimal medium that contains 40 μg/ml of all 20 proteogenic amino acids, or medium B (striped bars), which is a supplemented M9 minimal medium with 40 μg/ml of 18 proteogenic amino acids, 10 μg/ml Tyr, 40 μg/ml m-Tyr, and no Phe. Error bars represent standard deviations from 3 biological replicates. *, P value < 0.04; statistical analysis was performed using multiple t tests.

Intracellular nucleotide concentrations indicate a reduction in metabolic activity when persistence increases.

The intracellular nucleotide concentrations were determined by letting the wild-type pheS/pheT and all three mutants in both the relA+ and ΔrelA backgrounds grow in medium A and medium B to early log phase. Metabolites were extracted and then analyzed by liquid chromatography-mass spectrometry (LC-MS). There was a general trend of having a lower intracellular nucleotide concentration in the strains that showed elevated levels of persistence (Table 2), indicating a lower level of metabolic activity in these cells. These strains all have quality control present, but their stringent response has been disrupted. Bacterial antibiotic persister cells are able to evade killing by antibiotics because they have a low metabolic state and antibiotics mostly target actively growing cells. Also, the strains that resulted in very low levels of persistence had a higher intracellular concentration of ppGpp. The stringent response is activated by RelA in response to amino acid stress by synthesizing the alarmone ppGpp, so these cells were able to respond to the nutritional stress and did not enter into a persistent state. The highest levels of antibiotic persistence that were observed were in the strains that have quality control present and are in the ΔrelA background. This would indicate that these persister cells are independent of the production of ppGpp. The editing-deficient mutant, pheT G318W, in the ΔrelA background grown in medium B had elevated intracellular levels of AMP and GMP, indicative of ATP and GTP hydrolysis compared to when this strain was grown in medium A. These data are broadly inversely correlated with the changes in levels of persistence (Fig. 1), indicating that when quality control is absent, the ability to enter into persistence is significantly reduced.

TABLE 2.

Intracellular nucleotide concentrationsa

ATP (μM) ADP (μM) AMP (μM) GTP (μM) GDP (μM) GMP (μM) Cyclic di-GMP (μM) ppGpp (μM)
WT pheS/pheT relA+-A 338 428 991 51 237 1,100 1.1 10
relA+-B 266 315 665 43 238 908 1.8 6.1
ΔrelA-A 238 219 245 32 117 265 0.5 2.8
ΔrelA-B 185 155 218 24 88 247 1.0 2.6
pheT G318W relA+-A 252 329 745 36 187 925 1.4 3.1
relA+-B 274 344 797 40 238 908 1.2 7.1
ΔrelA-A 243 225 175 31 126 201 0.7 2.2
ΔrelA-B 245 302 421 32 172 513 0.8 3.8
pheS A294G relA+-A 195 174 201 32 160 309 3.7 3.2
relA+-B 161 162 253 22 143 419 1.9 2.0
ΔrelA-A 206 187 229 26 109 244 0.6 2.3
ΔrelA-B 133 136 179 16 85 177 0.7 1.9
pheS A294S relA+-A 179 181 247 31 165 462 3.0 3.9
relA+-B 152 188 279 26 158 455 7.0 3.5
ΔrelA-A 194 176 234 25 116 289 0.4 1.9
ΔrelA-B 101 104 141 13 89 159 1.2 2.7
a

Both E. coli MG1655 relA+ and ΔrelA strains were grown in medium A (containing all 20 amino acids) and medium B (containing no Phe, a lower Tyr concentration, and added m-Tyr) for all 4 PheRS strains. Concentrations are an average from biological triplicates and experimental triplicates.

The active site mutant, pheS A294S, in the ΔrelA background grown in medium B had the highest level of antibiotic persistence and also had a consistently lower nucleotide pool than the other pheS A294S strains. It was also observed that when the stringent response is suppressed, which correlated with higher levels of persistence, there is a lower concentration of the secondary messenger cyclic di-GMP. These data support the idea that the strains that enter into antibiotic persistence have an overall lower intracellular metabolite pool.

Proteome homeostasis is disrupted in strains that have a higher rate of antibiotic persistence.

Total proteome analyses were performed by using wild-type pheS/pheT and pheS A294S strains in both the relA+ and ΔrelA backgrounds and grown in medium B to mid-log phase. After the proteins were digested, the smaller peptides were injected for LC-MS/MS analysis. There were a total of 2,351 proteins quantified across all samples including PheS, PheT, and PheA. These 3 proteins either had no change or were slightly overexpressed in the strains tested, which indicates that the expression of these proteins has not been affected by our strain construction or growth conditions. Overall, proteome homeostasis was disrupted for all strains compared to the wild-type pheS/pheT in the relA+ background (see Fig. S3A to E and Data Set S1 in the supplemental materials). Upon further investigation, we choose to focus the data analyses on the wild-type pheS/pheT in the relA+ and ΔrelA background and pheS A294S in the ΔrelA background. The differentially expressed proteins for wild-type pheS/pheT between relA+ and ΔrelA (Table S1) and pheS A294S mutant in the ΔrelA background versus the wild-type pheS/pheT in the relA+ background (Table S2) were used to develop a protein-protein interaction (PPI) network (Fig. 3).

FIG 3.

FIG 3

Protein homeostasis is disrupted during bacterial antibiotic persistence. Differential protein expression protein-protein interaction (PPI) network was performed for wild-type pheS/pheT and pheS A294S in relA+ and ΔrelA backgrounds grown in medium B. The differentially expressed proteins are represented by their fold change for either ΔrelA wild-type pheS/pheT versus relA+ wild-type pheS/pheT (inner ring) or ΔrelA pheS A294S versus relA+ wild-type pheS/pheT (outer ring). The E. coli gene name is shown in the node, and cellular processes for amino acid biosynthesis (green), drug metabolism (yellow), and nucleotide biosynthesis (pink) are highlighted. Edges are derived from previously determined protein-protein interactions within StringDB.

FIG S3

Disruption of proteome homeostasis represented by volcano plots. Total proteome analysis was performed on wild-type pheS and pheS A294S in either MG1655 relA+ or ΔrelA backgrounds grown in medium B. (A) relA+ pheS A294S versus relA+ wild-type pheS. (B) ΔrelA wild-type pheS versus relA+ wild-type pheS. (C) ΔrelA pheS A294S versus relA+ pheS A294S. (D) ΔrelA pheS A294S versus ΔrelA wild-type pheS. (E) ΔrelA pheS A294S versus relA+ wild-type pheS. Download FIG S3, PDF file, 0.1 MB (155.8KB, pdf) .

Copyright © 2021 Wood et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

TABLE S1

Differentially expressed proteins in ΔrelA WT pheS/pheT versus relA+ WT pheS/pheT grown in medium B. Download Table S1, DOCX file, 1.8 MB (1.9MB, docx) .

Copyright © 2021 Wood et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

TABLE S2

Differentially expressed proteins in ΔrelA pheS A294S versus relA+ WT pheS/pheT grown in medium B. Download Table S2, DOCX file, 1.8 MB (1.8MB, docx) .

Copyright © 2021 Wood et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

DATA SET S1

Total proteome analysis. Changes in protein abundance were monitored for wild-type pheS and pheS A294S in either MG1655 relA+ and ΔrelA backgrounds grown in medium B. Over- and underrepresented proteins are noted. Download Data Set S1, XLSX file, 1.2 MB (1.3MB, xlsx) .

Copyright © 2021 Wood et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

The PPI network showed several proteins that were differentially expressed in pathways for cellular amino acid biosynthesis, drug metabolism, and nucleotide biosynthesis (represented by the green, yellow, and pink nodes, respectively, in Fig. 3). In general, the proteins involved in amino acid biosynthesis were downregulated in the pheS A294S strains (represented by the outer ring in Fig. 3) and were either slightly downregulated or had no change in the wild-type pheS/pheT (represented by the inner ring in Fig. 3). These results are consistent with pheS A294S having a higher fraction of persisters than the wild-type pheS/pheT in the ΔrelA background compared to the relA+ background (Fig. 1). Strikingly, MazF and MazG were both enriched in all strains compared to the wild-type pheS/pheT in the relA+ background. MazF is an RNase toxin that comprises part of the MazEF toxin-antitoxin module which has been previously studied in persister formation in E. coli (33, 34). MazG is a broad-specificity nucleoside triphosphatase (NTPase) that modulates MazEF and is involved in regulating cell survival under amino acid starvation conditions (35, 36).

DISCUSSION

Aminoacyl-tRNA synthetase quality control is a determinant for antibiotic persistence.

Aminoacyl-tRNA synthetase quality control is important for accurate synthesis of the proteome. When quality control is absent, misacylation of tRNAs can occur, which was once thought to always be detrimental to the cell, but it is now understood that in certain cases a low level of mistranslation can be beneficial for the cell to adapt to a new or challenging environment (27, 37). It was previously observed that when PheRS quality control is abolished by the use of a PheRS editing-deficient E. coli strain, pheT G318W, the cells were not able to activate the stringent response (25). The stringent response is critical for bacteria to withstand amino acid stress, and it is activated when deacylated-tRNA enters the A-site of the ribosome which signals for RelA to begin synthesizing the alarmone (p)ppGpp (38). When the PheRS editing-deficient strain is grown under starvation conditions and in the presence of m-Tyr, a nonproteogenic amino acid that is produced from the oxidation of Phe, misacylated m-Tyr-tRNAPhe falsely inhibits the stringent response from being triggered because it senses starvation via deacylated-tRNA and not misacylated-tRNA (25). The stringent response has been thought to be a determinant for antibiotic persistence; however, there have been a few studies where persistence has been shown to be stringent response independent (12, 13, 20).

In this study, we have investigated the effects of PheRS quality control on bacterial antibiotic persistence in E. coli. Along with the editing-deficient PheRS, we chose to study two different active site PheRS mutants, αA294G and αA294S. It is assumed that the αA294G mutation would have decreased substrate discrimination and the αA294S mutation would have increased discrimination (32). The αA294G PheRS is unable to discriminate between Phe and m-Tyr and has a 12.7-fold reduction in discrimination for Tyr compared to wild-type PheRS. However, αA294S PheRS has a 16.8-fold increase and a 2.6-fold increase of discrimination for m-Tyr and Tyr, respectively, compared to wild-type PheRS (Table 1). With these kinetic data, it can be hypothesized that αA294G PheRS will be able to efficiently synthesize m-Tyr-tRNAPhe; however, because editing is intact, the misacylated m-Tyr-tRNAPhe will be moved into the editing site of PheRS where it will be hydrolyzed (see Fig. S4A in the supplemental material). αA294G PheRS also has decreased efficiency for phenylalanine adenylation, and so, in addition to quality control, this mutant also fails to efficiently synthesize Phe-tRNAPhe, and this would also contribute to increased levels of deacylated tRNAPhe. With the increased discrimination of αA294S PheRS, it will not be able to synthesize m-Tyr-tRNAPhe (Fig. S4B). In both of these scenarios, the amount of the intracellular deacylated tRNAPhe would increase, and under starvation conditions, it would activate the stringent response.

FIG S4

Molecular model of increased deacylated tRNAPhe in the cell. (A) Reaction of active site mutant αA294G PheRS, which has decreased specificity for m-Tyr and Tyr compared to wild-type PheRS. The noncognate amino acid will be efficiently aminoacylated onto tRNAPhe, which will be moved to the editing site where hydrolysis of the misacylated tRNAPhe will occur. Deacylated tRNAPhe and noncognate amino acid will be released from PheRS. (B) Reaction of active site mutant αA294S PheRS, which has increased specificity for m-Tyr and Tyr compared to wild-type PheRS. The noncognate amino acid will not bind and therefore will not be aminoacylated onto tRNAPhe. Download FIG S4, PDF file, 0.1 MB (92.4KB, pdf) .

Copyright © 2021 Wood et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

Three different PheRS-encoding mutations, pheT G318W, pheS A294G, and pheS A294S, were made on the chromosome of E. coli MG1655 and the corresponding ΔrelA strain. Intriguingly, there was a reduction in persistence in the pheT G318W ΔrelA strain grown under amino acid limitation (Fig. 1 and Fig. S1). In this strain, the misacylated m-Tyr-tRNAPhe is not edited and so the stringent response is not triggered since the amount of intracellular deacylated tRNAPhe does not change. This correlates with our previous finding that when pheT G318W is unable to edit m-Tyr-tRNAPhe this resulted in the stringent response being unable to be activated (25). These results seem to indicate that when the intracellular concentration of deacylated tRNAPhe increases and a stringent response is able to be mounted, the cell responds appropriately; however, when RelA is not present, and the stringent response is disrupted, the cell can directly enter into a persistent state.

Deacylated tRNA triggers antibiotic persistence independent of the stringent response.

Taken together, the kinetic data and the antibiotic persistence data suggest that the intracellular level of deacylated tRNA may ultimately be a trigger for persistence. To investigate this further, Northern blot analysis was performed on all 4 PheRS strains in both the relA+ and ΔrelA E. coli background, which did confirm that the amount of aminoacylated tRNAPhe significantly decreased in both pheS A294G and pheS A294S in the ΔrelA background when grown in medium B (Fig. 2). This decrease in aminoacylated tRNAPhe correlates with these two strains displaying the greatest persistence. Our data support that the increase in persistence in the ΔrelA E. coli background is consistent with an increase in intracellular deacylated tRNAPhe concentrations and is independent of the stringent response. We attempted to further investigate persistence and the connection to deacylated tRNA accumulation using a pheS A294G/pheT G318W double mutant, but this strain had a severe growth defect when grown in medium B, and this growth defect was even more pronounced in the ΔrelA background (Fig. S2).

Other studies have proposed that when aaRS activity is restricted or inhibited, the amount of deacylated tRNA in the cell would increase and this may be the trigger for antibiotic persistence, consistent with our data shown here (16, 2022). In several previous studies, it was shown that GluRS was inactivated by phosphorylation via the toxin HipA, leading to limited tRNAGlu aminoacylation and increased levels of persistence. When this occurs, the amount of deacylated tRNAGlu increases and it enters the A-site of the ribosome, triggering the stringent response via RelA; thus, this mechanism of persistence is RelA dependent (16, 22). Interestingly, a few of these studies were conducted in bacteria that lack RelA and have a disrupted stringent response. One study was conducted using Chlamydia, a Trp auxotroph, and the authors used indolmycin to inhibit TrpRS, which led to a decrease in aminoacylated tRNATrp that reduced translation rates and increased persistence. Since Chlamydia does not encode RelA or SpoT, this mechanism of persistence is stringent response independent (20). A few studies have been conducted in Caulobacter crescentus, which relies solely on SpoT to regulate the stringent response which requires both amino acid limitation and carbon or nitrogen starvation. In one study, HipA was able to phosphorylate both GluRS and TrpRS, which inhibited their aminoacylation activity, and upon a further carbon or nitrogen stress, SpoT would synthesize (p)ppGpp and the cells would enter into a persister state (21). In another study, the HipA phosphorylation of TrpRS was further investigated, and it was found that as the levels of Trp increase in the cell because it is not being used to aminoacylate tRNATrp, this led to the inhibition of GlnE, which reduced the amount of glutamine production, creating a nitrogen shortage. This imbalance in amino acids ultimately resulted in an increase in persister cells that is SpoT dependent (39).

There has also been a recent study showing that defects in tRNA, such as a lack in methylation, seem to have a link to antibiotic resistance and persistence (40, 41). In the present study, the highest levels of persistence were associated with increased levels of deacylated tRNAPhe and when RelA was deleted. SpoT is encoded in our ΔrelA strains, accounting for our ability to detect ppGpp. In all the ΔrelA strains, ppGpp levels remained steady regardless of amino acid limitation, suggesting that SpoT activity was not significantly altered when persistence was increased.

Changes in metabolism reveal a cellular reprogramming in antibiotic persister cells.

Metabolomics and proteomics were performed in order to further understand the metabolic state of the different strains that were used in this study. The metabolomics data showed an overall trend of decreased intracellular concentrations of nucleotides compared to the wild-type strain (Table 2). For example, the strain with the highest level of persistence, ΔrelA pheS A294S grown in medium B, had a reduced concentration of the nucleotides tested except for cyclic di-GMP and ppGpp compared to the other pheS A294S strains. This is consistent with antibiotic persister cells having a low biochemical and metabolic state because they are in a dormant, nongrowing form. There was also a general trend of AMP and GMP having a higher intracellular concentration compared to their di- and triphosphate purine nucleotides, which is also consistent with persistent cells being in a low energetic state.

The proteomics data showed that cellular homeostasis was disrupted for wild-type pheS/pheT and pheS A294S in the ΔrelA background compared to wild-type pheS/pheT in the relA+ background when grown in medium B (Fig. 3). From the PPI network, it was observed that most of the proteins that are involved in amino acid biosynthesis were underrepresented compared to wild-type pheS/pheT in the relA+ background which is consistent with the cells entering into a dormant state. Furthermore, from the proteomics data PheA was overexpressed in pheS A294S in the ΔrelA background. Expression of PheA is required for the biosynthesis of phenylalanine and is regulated by transcription attenuation by the synthesis of the leader peptide PheL. Under normal conditions, PheRS maintains the level of Phe-tRNAPhe for the attenuation of pheA transcription (25, 42). However, pheS A294S in the ΔrelA background led to an increased amount of deacylated tRNAPhe when grown in medium B, and this also led to the increased expression of PheA, which further supports our model. Furthermore, PheA had normal levels of expression when comparing the proteomics data of wild-type pheS/pheT in the ΔrelA background compared to the relA+ background, indicating that deletion of relA does not affect the transcription of pheA.

The toxin MazF was significantly enriched in both wild-type pheS/pheT and pheS A294S in the ΔrelA background, and the antitoxin MazE was not detected above the limit of detection. MazEF is a type II toxin-antitoxin module in which when the labile antitoxin, MazE, is degraded in the cell MazF can cause toxicity by cleaving mRNA, which may occur independent of translation (43). The regulator of the MazEF module, MazG, was also upregulated. MazG is an NTP hydrolase that can cleave (p)ppGpp produced by RelA or SpoT and also hydrolyze the NTP substrates for the synthesis of (p)ppGpp (35, 36). Since the upregulated MazG was observed in the ΔrelA background, it could be hypothesized that the (p)ppGpp that MazG would be degrading is being produced from SpoT. It is also possible that MazG might be degrading NTPs to prevent the synthesis of (p)ppGpp, since it was observed from the metabolomics that ATP and GTP concentrations were reduced in these strains. Furthermore, to ensure that the increase in the expression levels of MazF and MazG was not an artifact of transcriptional read-through from the disruption of relA using a kanamycin cassette, sequencing of this operon was performed (data not shown). We confirmed that both the 5′ untranslated region (UTR) and 3′ end of relA are intact and that the 5′ region of mazEF, which contains both of its promoters, was not disrupted by the kanamycin insertion into the relA gene. Both of these promoters are required for the autoregulation of mazEF, and when MazE is degraded, MazF is released as a toxin (44, 45). The promoter for mazG was also not disrupted, which indicates that the increased levels of expression for both MazF and MazG are due to the cells having entered into an antibiotic persister state. There were also changes in the levels of production for numerous proteins involved in fatty acid synthesis, purine biosynthesis, and the tricarboxylic acid cycle, which have previously been shown to be disrupted when bacterial persistence is triggered (4648). It should also be noted that for both the metabolomics and proteomics experiments, the entire bacterial population was used for the metabolite and protein extractions, so the quantifications are an average of the population. Since bacterial persisters represent only a small fraction of the entire population (∼1 to 10% in this study), these subtle changes in the metabolite concentration and protein expression may be more pronounced in the persister cell. Naturally occurring or spontaneous persister cells occur at a frequency of ∼1 × 10−6, and mistranslation occurs every ∼1 × 10−4 codons (27, 49). As these small frequencies in error begin to accumulate, so the rate of bacterial persister formation increases.

Our data reveal a mechanism for persister formation where reduced translation capacity is accompanied by accelerated depletion of cellular NTP pools, which in turn triggers antibiotic persistence. Our data further show that the frequency of persister formation via this mechanism is significantly influenced by the specificity and efficiency with which substrates for translation are synthesized. While in our study changes in PheRS specificity and efficiency were achieved via genetic manipulation, nutrient depletion can also have comparable effects on aminoacyl-tRNA synthesis in wild-type cells (50). This mechanism of bacterial persister formation is ppGpp independent. Our study and several other studies have recently been challenging the role of RelA and ppGpp in persister formation. Instead, changes in amino acid concentrations, inhibition of aaRSs, and slowed translation are all mechanisms now known to be able to induce bacterial antibiotic persistence. Taken together, these and previous findings suggest that small amino acid imbalances, while not significantly impacting the population as a whole, could lead to heterogenous quality control outcomes that affect a small number of cells, thereby triggering the formation of a subpopulation of antibiotic persisters.

MATERIALS AND METHODS

Strains, plasmids, and general methods.

All strains were constructed in either a relA+ E. coli (MG1655) background or a ΔrelA E. coli background (51). An editing-deficient PheRS E. coli strain, pheT G318W, was previously made (25, 29). Two different mutant E. coli strains, pheS A294G and pheS A294S, were constructed using scarless Cas9-assisted recombineering (no-SCAR) (30, 31). Briefly, pKDsgRNA-pheS was made using round-the-horn cloning with pKDsgRNA-ackA, and primers for PCR were as follows: F-sgRNA pheS, 5′-ATCGACCCGGAAGTTTACTCGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGG-3′, and PtetR, 5′-PO4-GTGCTCAGTATCTCTATCACTGA-3′. After pCas9Cr4 was chemically transformed into the host strain, pKDsgRNA-pheS was transformed by electroporation. Colonies that contained both plasmids were grown in super optimal broth medium with shaking at 30°C. When the optical density at 600 nm (OD600) reached 0.1 to 0.2, λ-red expression was induced with 0.2% arabinose. Once the culture reached an OD600 of 0.4 to 0.6, 2 μM single-stranded DNA (ssDNA) recombineering oligonucleotide that contained the desired mutation was transformed by electroporation. The pheS A294G oligonucleotide sequence was 5′-AACGCAACATAGTCAGACGCTCCATCCCCATCCCAAACCCAAAACCGCTATAAACTTCGGGATCAATGCCAACGTTACGC-3′, and the pheS A294S oligonucleotide sequence was 5′-AACGCAACATAGTCAGACGCTCCATCCCCATCCCAAAGCTAAAACCGCTATAAACTTCGGGATCAATGCCAACGTTACGC-3′. Both recombineering oligonucleotides had four phosphorothioate bonds at the 5′ end of the oligonucleotide. Recombineering occurred at 30°C for 2 h while shaking. Counterselection is achieved by induction of Cas9 with anhydrotetracycline. pKDsgRNA-pheS and pCas9Cr4 curing was performed exactly as described previously (31). Clones were screened by colony PCR using forward primer 5′-CTCGCAGAACTGGTTGCCAG-3′ and reverse primer 5′-CACGCAGTTTGTCAGCGTTCG-3′. Clones were confirmed by DNA sequencing using forward primer 5′-CTGATTGTTGATACCAACATC-3′. E. coli XL1-Blue/pQE31-FRS (producing His6-tagged wild-type PheRS) and E. coli XL1-Blue/pQE31-pheSA294G (producing His6-tagged αA294G PheRS) were previously constructed (52). A point mutation was made in the pheS gene of pQE31-FRS by PCR-based site-directed mutagenesis using two self-complementary primers (5′-ACTCTGGTTTCAGCTTCGGGATGG-3′) to generate E. coli XL1-Blue/pQE31-pheSA294S (producing His6-tagged αA294S PheRS). The mutation was confirmed by DNA sequencing. Protein expression and purification were performed essentially as described previously (53).

ATP/PPi exchange.

Detailed description of the methods for ATP/PPi exchange to determine steady-state kinetics of amino acid activation are in Text S1 in the supplemental material.

TEXT S1

Methods and Materials. Download Text S1, DOCX file, 0.02 MB (22.7KB, docx) .

Copyright © 2021 Wood et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

Growth medium.

Lysogeny broth (LB) was made with 0.5% NaCl, 0.5% yeast extract, and 1% tryptone. A supplemented M9 minimal medium that was used for persister assays was developed based on a previous protocol (14). A 2× supplemented M9 minimal medium was prepared as follows: 2× M9 salts, 0.8% glucose, 4 mM MgSO4, 0.2 mM CaCl2, 2 μg/ml thiamine, 1 μg/ml FeSO4 solution, 80 μg/ml all proteogenic amino acids except for phenylalanine and tyrosine. For the persister assays, two different media were used, medium A and medium B. Medium A contained 1× supplemented M9 minimal medium, 40 μg/ml phenylalanine, and 40 μg/ml tyrosine. Medium B contained 1× supplemented M9 minimal medium, 10 μg/ml tyrosine, and 40 μg/ml m-tyrosine (no phenylalanine was used in this medium).

Minimum duration of killing (MDK) persister assays.

MDK persister assays were performed as described in several studies (3, 4, 14, 54). Overnight cultures were grown in LB and were then diluted 1:100 into 6 ml of either medium A or medium B in culture tubes. The cultures were grown at 37°C while shaking at 250 rpm until they reached early exponential phase (OD600 = 0.2 to 0.3). At this point 1 ml of culture was taken out, serially diluted, and plated on LB plates to count CFU; 100 μg/ml ampicillin was added to the remaining culture; and growth continued at 37°C with shaking. Every hour for 3 h, 1 ml of culture was removed, washed in sterile phosphate-buffered saline (PBS) twice to remove the antibiotic, serially diluted, and plated on LB plates. To calculate persisters, the CFU of survivors after ampicillin treatment was divided by the CFU of the culture before ampicillin treatment.

Quantification of aminoacylated and deacylated tRNA.

Purification of total tRNA, acid/urea gel electrophoresis, and Northern blotting methods are described in detail in Text S1.

Targeted metabolomic analysis and quantification.

Metabolites were extracted from exponentially growing E. coli cells as described previously (55, 56). Detailed methods for the metabolite extraction are described in Text S1.

LC-MS analysis of the metabolites was performed as described previously (57). The dried metabolites were suspended in 50 μl of MilliQ water and centrifuged at 16,000 × g for 30 min at 4°C, and the supernatant was transferred to an LC vial. Separation of metabolites was performed on a Thermo Scientific UltiMate 3000 ultra-high performance liquid chromatography system equipped with a zwitter-ionic-phosphorylcholine hydrophilic interaction liquid chromatography, 150- by 2.1-mm, 3-μm column with a flow rate of 0.15 ml/min and a column temperature of 37°C; mobile phase A was 10 mM ammonium acetate, pH 6, and mobile phase B was 10% 10 mM ammonium acetate, pH 6, 90% acetonitrile. Chromatography gradient was as follows: isocratic 100% mobile phase B for 3 min, linear gradient to 20% B for 22 min, linear gradient to 100% B for 1 min, isocratic 100% B for 1 min, linear gradient to 20% B for 8 min, linear gradient to 100% B for 5 min, and isocratic 100% B for 15 min. Standard curves with a mixture of ATP, ADP, AMP, GTP, GDP, GMP, cyclic di-AMP, cyclic di-GMP, and ppGpp ranging from 0 to 5 ppm spiked with 10 ppm internal standard mix were done before and after each experimental set to ensure column integrity. The MS was performed on a Thermo Scientific TSQ Quantiva (triple-stage quadrupole MS) with a spray voltage of 3,500 V in the negative ion mode, ion vaporizer at 50°C, and ion transfer tube at 350°C. Analysis and quantification were performed using Xcalibur data acquisition and interpretation software. Intracellular concentrations were calculated assuming an OD600 of 1.0 equals 8 × 108 cells and that the volume of one E. coli cell growing in exponential phase equals 1 × 10−15 liter (58, 59). This was then normalized by the extraction efficiency for [13C]ATP and [13C]GTP.

Protein digestion and mass spectrometry. (i) Digestion of intact E. coli for shotgun proteomics.

Twenty-milliliter cultures were inoculated to a starting OD at 600 nm of 0.01 in either medium A or medium B using an overnight culture to stationary phase. After reaching mid-log, cells were chilled on ice and pelleted by centrifugation for 2 min at 8,000 rpm. The resulting pellet was frozen at −80°C for downstream processing. For cell lysis and protein digest, cell pellets were thawed on ice and 2 μl of cell pellet was transferred to a microcentrifuge tube containing 40 μl of lysis buffer (10 mM Tris-HCl, pH 8.6, 10 mM dithiothreitol [DTT], 1 mM EDTA, and 0.5% antilymphocyte serum [ALS]). Cells were lysed by vortex for 30 s, and disulfide bonds were reduced by incubating the reaction mixture for 30 min at 55°C. The reaction was briefly quenched on ice, and 16 μl of a 60 mM iodoacetamide solution was added. Alkylation of cysteines proceeded for 30 min in the dark. Excess iodoacetamide was quenched with 14 μl of a 25 mM DTT solution, and the sample was then diluted with 330 μl of 183 mM Tris-HCl buffer (pH 8.0) supplemented with 2 mM CaCl2. Proteins were digested overnight using 12 μg sequencing-grade trypsin. Following digestion, the reaction was then quenched with 12.5 μl of a 20% trifluoroacetic acid (TFA) solution, resulting in a sample pH of <3. Remaining ALS reagent was cleaved for 15 min at room temperature. The sample (∼30 μg protein) was desalted by reverse-phase cleanup using C18 UltraMicroSpin columns. The desalted peptides were dried at room temperature in a rotary vacuum centrifuge and reconstituted in 20 μl 70% formic acid-0.1% TFA (3:8 [vol/vol]) for peptide quantitation by UV280. The sample was diluted to a final concentration of 0.4 μg/μl, and 5 μl (2 μg) was injected for LC-MS/MS analysis.

(ii) Data acquisition and analysis.

LC-MS/MS was performed using an Acquity UPLC M-class (Waters) and Q Exactive Plus mass spectrometer. The analytical column employed was a 65-cm-long, 75-μm-internal-diameter PicoFrit column (New Objective) packed in-house to a length of 50 cm with 1.9-μm ReproSil-Pur 120-Å C18-AQ (Dr. Maisch) using methanol as the packing solvent. Peptide separation was achieved using mixtures of 0.1% formic acid in water (solvent A) and 0.1% formic acid in acetonitrile (solvent B) with a 90-min gradient of either 0/1, 2/7, 60/24, 65/48, 70/80, 75/80, 80/1, or 90/1 (min/% B, linear ramping between steps). Gradient was performed with a flow rate of 250 nl/min. At least one blank injection (5 μl 2% B) was performed between samples to eliminate peptide carryover on the analytical column. One hundred femtomoles of trypsin-digested bovine serum albumin (BSA) or 100 ng trypsin-digested wild-type K-12 MG1655 E. coli proteins was run periodically between samples as quality control standards.The mass spectrometer was operated with the following parameters: (MS1) 70,000 resolution, 3e6 automatic gain control (AGC) target, 300 to 1,700 m/z scan range; (data-dependent MS2) 17,500 resolution, 1e6 AGC target, top 10 mode, 1.6 m/z isolation window, 27 normalized collision energy, 90-s dynamic exclusion, unassigned, and +1 charge exclusion. Data were searched using MaxQuant version 1.6.10.43 with deamidation (NQ), oxidation (M), and phospho (STY) as variable modifications and carbamidomethyl (C) as a fixed modification with up to 3 missed cleavages, 5-amino-acid (aa) minimum length, and 1% false-discovery rate (FDR) against a UniProt E. coli database. Search results were analyzed with Perseus version 1.6.2.2.

ACKNOWLEDGMENTS

We thank Gregory Phillips and Paul Kelly for insightful thoughts on the manuscript and scientific discussion.

This work was funded by the Army Research Office (award no. W911NF-20-1-0152 to M.I.) and the NIH (award no. 5F32CA224946-03 to K.M.).

Footnotes

This article is a direct contribution from Michael Ibba, a Fellow of the American Academy of Microbiology, who arranged for and secured reviews by Christopher Hayes, University of California, Santa Barbara, and Graeme Conn, Emory University School of Medicine.

Citation Wood WN, Mohler K, Rinehart J, Ibba M. 2021. Deacylated tRNA accumulation is a trigger for bacterial antibiotic persistence independent of the stringent response. mBio 12:e01132-21. https://doi.org/10.1128/mBio.01132-21.

Contributor Information

Michael Ibba, Email: ibba@chapman.edu.

Houra Merrikh, Vanderbilt University.

REFERENCES

  • 1.Lewis K. 2007. Persister cells, dormancy and infectious disease. Nat Rev Microbiol 5:48–56. doi: 10.1038/nrmicro1557. [DOI] [PubMed] [Google Scholar]
  • 2.Fisher RA, Gollan B, Helaine S. 2017. Persistent bacterial infections and persister cells. Nat Rev Microbiol 15:453–464. doi: 10.1038/nrmicro.2017.42. [DOI] [PubMed] [Google Scholar]
  • 3.Balaban NQ, Helaine S, Lewis K, Ackermann M, Aldridge B, Andersson DI, Brynildsen MP, Bumann D, Camilli A, Collins JJ, Dehio C, Fortune S, Ghigo JM, Hardt WD, Harms A, Heinemann M, Hung DT, Jenal U, Levin BR, Michiels J, Storz G, Tan MW, Tenson T, Van Melderen L, Zinkernagel A. 2019. Definitions and guidelines for research on antibiotic persistence. Nat Rev Microbiol 17:441–448. doi: 10.1038/s41579-019-0196-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Brauner A, Fridman O, Gefen O, Balaban NQ. 2016. Distinguishing between resistance, tolerance and persistence to antibiotic treatment. Nat Rev Microbiol 14:320–330. doi: 10.1038/nrmicro.2016.34. [DOI] [PubMed] [Google Scholar]
  • 5.Balaban NQ, Gerdes K, Lewis K, McKinney JD. 2013. A problem of persistence: still more questions than answers? Nat Rev Microbiol 11:587–591. doi: 10.1038/nrmicro3076. [DOI] [PubMed] [Google Scholar]
  • 6.Moyed HS, Bertrand KP. 1983. hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J Bacteriol 155:768–775. doi: 10.1128/JB.155.2.768-775.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Slattery A, Victorsen AH, Brown A, Hillman K, Phillips GJ. 2013. Isolation of highly persistent mutants of Salmonella enterica serovar Typhimurium reveals a new toxin-antitoxin module. J Bacteriol 195:647–657. doi: 10.1128/JB.01397-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Girgis HS, Harris K, Tavazoie S. 2012. Large mutational target size for rapid emergence of bacterial persistence. Proc Natl Acad Sci U S A 109:12740–12745. doi: 10.1073/pnas.1205124109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Cameron DR, Shan Y, Zalis EA, Isabella V, Lewis K. 2018. A genetic determinant of persister cell formation in bacterial pathogens. J Bacteriol 200:e00303-18. doi: 10.1128/JB.00303-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Harms A, Maisonneuve E, Gerdes K. 2016. Mechanisms of bacterial persistence during stress and antibiotic exposure. Science 354:aaf4268. doi: 10.1126/science.aaf4268. [DOI] [PubMed] [Google Scholar]
  • 11.Gerdes K, Maisonneuve E. 2012. Bacterial persistence and toxin-antitoxin loci. Annu Rev Microbiol 66:103–123. doi: 10.1146/annurev-micro-092611-150159. [DOI] [PubMed] [Google Scholar]
  • 12.Shan Y, Brown Gandt A, Rowe SE, Deisinger JP, Conlon BP, Lewis K. 2017. ATP-dependent persister formation in Escherichia coli. mBio 8:e02267-16. doi: 10.1128/mBio.02267-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Chowdhury N, Kwan BW, Wood TK. 2016. Persistence Increases in the absence of the alarmone guanosine tetraphosphate by reducing cell growth. Sci Rep 6:20519. doi: 10.1038/srep20519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Harms A, Fino C, Sorensen MA, Semsey S, Gerdes K. 2017. Prophages and growth dynamics confound experimental results with antibiotic-tolerant persister cells. mBio 8:e01964-17. doi: 10.1128/mBio.01964-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Conlon BP, Rowe SE, Gandt AB, Nuxoll AS, Donegan NP, Zalis EA, Clair G, Adkins JN, Cheung AL, Lewis K. 2016. Persister formation in Staphylococcus aureus is associated with ATP depletion. Nat Microbiol 1:16051. doi: 10.1038/nmicrobiol.2016.51. [DOI] [PubMed] [Google Scholar]
  • 16.Germain E, Castro-Roa D, Zenkin N, Gerdes K. 2013. Molecular mechanism of bacterial persistence by HipA. Mol Cell 52:248–254. doi: 10.1016/j.molcel.2013.08.045. [DOI] [PubMed] [Google Scholar]
  • 17.Levin-Reisman I, Ronin I, Gefen O, Braniss I, Shoresh N, Balaban NQ. 2017. Antibiotic tolerance facilitates the evolution of resistance. Science 355:826–830. doi: 10.1126/science.aaj2191. [DOI] [PubMed] [Google Scholar]
  • 18.Garoff L, Huseby DL, Praski Alzrigat L, Hughes D. 2018. Effect of aminoacyl-tRNA synthetase mutations on susceptibility to ciprofloxacin in Escherichia coli. J Antimicrob Chemother 73:3285–3292. doi: 10.1093/jac/dky356. [DOI] [PubMed] [Google Scholar]
  • 19.Khare A, Tavazoie S. 2020. Extreme antibiotic persistence via heterogeneity-generating mutations targeting translation. mSystems 5:e00847-19. doi: 10.1128/mSystems.00847-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Hatch ND, Ouellette SP. 2020. Inhibition of tRNA synthetases induces persistence in Chlamydia. Infect Immun 88:e00943-19. doi: 10.1128/IAI.00943-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Huang CY, Gonzalez-Lopez C, Henry C, Mijakovic I, Ryan KR. 2020. hipBA toxin-antitoxin systems mediate persistence in Caulobacter crescentus. Sci Rep 10:2865. doi: 10.1038/s41598-020-59283-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Kaspy I, Rotem E, Weiss N, Ronin I, Balaban NQ, Glaser G. 2013. HipA-mediated antibiotic persistence via phosphorylation of the glutamyl-tRNA-synthetase. Nat Commun 4:3001. doi: 10.1038/ncomms4001. [DOI] [PubMed] [Google Scholar]
  • 23.Ibba M, Soll D. 2000. Aminoacyt-tRNA synthetases. Annu Rev Biochem 69:617–650. doi: 10.1146/annurev.biochem.69.1.617. [DOI] [PubMed] [Google Scholar]
  • 24.Stephens RS, Kalman S, Lammel C, Fan J, Marathe R, Aravind L, Mitchell W, Olinger L, Tatusov RL, Zhao Q, Koonin EV, Davis RW. 1998. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 282:754–759. doi: 10.1126/science.282.5389.754. [DOI] [PubMed] [Google Scholar]
  • 25.Bullwinkle TJ, Ibba M. 2016. Translation quality control is critical for bacterial responses to amino acid stress. Proc Natl Acad Sci U S A 113:2252–2257. doi: 10.1073/pnas.1525206113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Kelly P, Backes N, Mohler K, Buser C, Kavoor A, Rinehart J, Phillips G, Ibba M. 2019. Alanyl-tRNA synthetase quality control prevents global dysregulation of the Escherichia coli proteome. mBio 10:e02921-19. doi: 10.1128/mBio.02921-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Mohler K, Ibba M. 2017. Translational fidelity and mistranslation in the cellular response to stress. Nat Microbiol 2:17117. doi: 10.1038/nmicrobiol.2017.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Bullwinkle T, Lazazzera B, Ibba M. 2014. Quality control and infiltration of translation by amino acids outside of the genetic code. Annu Rev Genet 48:149–166. doi: 10.1146/annurev-genet-120213-092101. [DOI] [PubMed] [Google Scholar]
  • 29.Bullwinkle TJ, Reynolds NM, Raina M, Moghal A, Matsa E, Rajkovic A, Kayadibi H, Fazlollahi F, Ryan C, Howitz N, Faull KF, Lazazzera BA, Ibba M. 2014. Oxidation of cellular amino acid pools leads to cytotoxic mistranslation of the genetic code. Elife 3:e02501. doi: 10.7554/eLife.02501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Reisch CR, Prather KL. 2015. The no-SCAR (Scarless Cas9 Assisted Recombineering) system for genome editing in Escherichia coli. Sci Rep 5:15096. doi: 10.1038/srep15096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Reisch CR, Prather KLJ. 2017. Scarless Cas9 Assisted Recombineering (no-SCAR) in Escherichia coli, an easy-to-use system for genome editing. Curr Protoc Mol Biol 117:31.8.1–31.8.20. doi: 10.1002/cpmb.29. [DOI] [PubMed] [Google Scholar]
  • 32.Ibba M, Kast P, Hennecke H. 1994. Substrate specificity is determined by amino acid binding pocket size in Escherichia coli phenylalanyl-tRNA synthetase. Biochemistry 33:7107–7112. doi: 10.1021/bi00189a013. [DOI] [PubMed] [Google Scholar]
  • 33.Tripathi A, Dewan PC, Siddique SA, Varadarajan R. 2014. MazF-induced growth inhibition and persister generation in Escherichia coli. J Biol Chem 289:4191–4205. doi: 10.1074/jbc.M113.510511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Cho J, Carr AN, Whitworth L, Johnson B, Wilson KS. 2017. MazEF toxin-antitoxin proteins alter Escherichia coli cell morphology and infrastructure during persister formation and regrowth. Microbiology (Reading) 163:308–321. doi: 10.1099/mic.0.000436. [DOI] [PubMed] [Google Scholar]
  • 35.Gross M, Marianovsky I, Glaser G. 2006. MazG – a regulator of programmed cell death in Escherichia coli. Mol Microbiol 59:590–601. doi: 10.1111/j.1365-2958.2005.04956.x. [DOI] [PubMed] [Google Scholar]
  • 36.Lee S, Kim MH, Kang BS, Kim JS, Kim GH, Kim YG, Kim KJ. 2008. Crystal structure of Escherichia coli MazG, the regulator of nutritional stress response. J Biol Chem 283:15232–15240. doi: 10.1074/jbc.M800479200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Rathnayake UM, Wood WN, Hendrickson TL. 2017. Indirect tRNA aminoacylation during accurate translation and phenotypic mistranslation. Curr Opin Chem Biol 41:114–122. doi: 10.1016/j.cbpa.2017.10.009. [DOI] [PubMed] [Google Scholar]
  • 38.Hauryliuk V, Atkinson GC, Murakami KS, Tenson T, Gerdes K. 2015. Recent functional insights into the role of (p)ppGpp in bacterial physiology. Nat Rev Microbiol 13:298–309. doi: 10.1038/nrmicro3448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Zhou X, Eckart MR, Shapiro L. 2021. A bacterial toxin perturbs intracellular amino acid balance to induce persistence. mBio 12:e03020-20. doi: 10.1128/mBio.03020-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Masuda I, Matsubara R, Christian T, Rojas ER, Yadavalli SS, Zhang L, Goulian M, Foster LJ, Huang KC, Hou YM. 2019. tRNA methylation is a global determinant of bacterial multi-drug resistance. Cell Syst 8:302–314.e8. doi: 10.1016/j.cels.2019.03.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Hou YM, Masuda I, Foster LJ. 2020. tRNA methylation: an unexpected link to bacterial resistance and persistence to antibiotics and beyond. Wiley Interdiscip Rev RNA 11:e1609. doi: 10.1002/wrna.1609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Borg-Olivier SA, Tarlinton D, Brown KD. 1987. Defective regulation of the phenylalanine biosynthetic operon in mutants of the phenylalanyl-tRNA synthetase operon. J Bacteriol 169:1949–1953. doi: 10.1128/jb.169.5.1949-1953.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Christensen-Dalsgaard M, Gerdes K. 2008. Translation affects YoeB and MazF messenger RNA interferase activities by different mechanisms. Nucleic Acids Res 36:6472–6481. doi: 10.1093/nar/gkn667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Aizenman E, Engelberg-Kulka H, Glaser G. 1996. An Escherichia coli chromosomal “addiction module” regulated by 3’,5’-bispyrophosphate: a model for programmed bacterial cell death. Proc Natl Acad Sci U S A 93:6059–6063. doi: 10.1073/pnas.93.12.6059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Marianovsky I, Aizenman E, Engelberg-Kulka H, Glaser G. 2001. The regulation of the Escherichia coli mazEF promoter involves an unusual alternating palindrome. J Biol Chem 276:5975–5984. doi: 10.1074/jbc.M008832200. [DOI] [PubMed] [Google Scholar]
  • 46.Sinha AK, Winther KS, Roghanian M, Gerdes K. 2019. Fatty acid starvation activates RelA by depleting lysine precursor pyruvate. Mol Microbiol 112:1339–1349. doi: 10.1111/mmi.14366. [DOI] [PubMed] [Google Scholar]
  • 47.Wang B, Grant RA, Laub MT. 2020. ppGpp coordinates nucleotide and amino-acid synthesis in E. coli during starvation. Mol Cell 80:29–42.e10. doi: 10.1016/j.molcel.2020.08.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Zalis EA, Nuxoll AS, Manuse S, Clair G, Radlinski LC, Conlon BP, Adkins J, Lewis K. 2019. Stochastic variation in expression of the tricarboxylic acid cycle produces persister cells. mBio 10:e01930-19. doi: 10.1128/mBio.01930-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Balaban NQ, Merrin J, Chait R, Kowalik L, Leibler S. 2004. Bacterial persistence as a phenotypic switch. Science 305:1622–1625. doi: 10.1126/science.1099390. [DOI] [PubMed] [Google Scholar]
  • 50.Raina M, Moghal A, Kano A, Jerums M, Schnier PD, Luo S, Deshpande R, Bondarenko PV, Lin H, Ibba M. 2014. Reduced amino acid specificity of mammalian tyrosyl-tRNA synthetase is associated with elevated mistranslation of Tyr codons. J Biol Chem 289:17780–17790. doi: 10.1074/jbc.M114.564609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, Datsenko KA, Tomita M, Wanner BL, Mori H. 2006. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol 2:2006.0008. doi: 10.1038/msb4100050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Roy H, Ling J, Irnov M, Ibba M. 2004. Post-transfer editing in vitro and in vivo by the beta subunit of phenylalanyl-tRNA synthetase. EMBO J 23:4639–4648. doi: 10.1038/sj.emboj.7600474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Roy H, Ling J, Alfonzo J, Ibba M. 2005. Loss of editing activity during the evolution of mitochondrial phenylalanyl-tRNA synthetase. J Biol Chem 280:38186–38192. doi: 10.1074/jbc.M508281200. [DOI] [PubMed] [Google Scholar]
  • 54.Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K. 2004. Persister cells and tolerance to antimicrobials. FEMS Microbiol Lett 230:13–18. doi: 10.1016/S0378-1097(03)00856-5. [DOI] [PubMed] [Google Scholar]
  • 55.Park JO, Rubin SA, Xu YF, Amador-Noguez D, Fan J, Shlomi T, Rabinowitz JD. 2016. Metabolite concentrations, fluxes and free energies imply efficient enzyme usage. Nat Chem Biol 12:482–489. doi: 10.1038/nchembio.2077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Crutchfield CA, Lu W, Melamud E, Rabinowitz JD. 2010. Mass spectrometry-based metabolomics of yeast. Methods Enzymol 470:393–426. doi: 10.1016/s0076-6879(10)70016-1. [DOI] [PubMed] [Google Scholar]
  • 57.Zbornikova E, Knejzlik Z, Hauryliuk V, Krasny L, Rejman D. 2019. Analysis of nucleotide pools in bacteria using HPLC-MS in HILIC mode. Talanta 205:120161. doi: 10.1016/j.talanta.2019.120161. [DOI] [PubMed] [Google Scholar]
  • 58.Varik V, Oliveira SRA, Hauryliuk V, Tenson T. 2017. HPLC-based quantification of bacterial housekeeping nucleotides and alarmone messengers ppGpp and pppGpp. Sci Rep 7:11022. doi: 10.1038/s41598-017-10988-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Volkmer B, Heinemann M. 2011. Condition-dependent cell volume and concentration of Escherichia coli to facilitate data conversion for systems biology modeling. PLoS One 6:e23126. doi: 10.1371/journal.pone.0023126. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

FIG S1

Minimum duration of killing (MDK) assays for different E. coli PheRS strains in both a relA+ and ΔrelA background. Cultures were grown to early log phase and then exposed to 100 μg/ml ampicillin for 3 h. Cultures were taken out every hour, washed in sterile PBS, and plated to calculate CFU. (A) WT pheS/pheT; (B) editing-deficient PheRS, pheT G318W; (C) active site mutant PheRS, pheS A294G; (D) active site mutant pheS A294S. In each panel, MDK assay was performed in relA+ E. coli (black lines), ΔrelA E. coli (colored lines), medium A (solid lines), and medium B (dashed lines). Medium A is a supplemented M9 minimal medium that contains 40 μg/ml of all 20 proteogenic amino acids, and medium B is a supplemented M9 minimal medium with 40 μg/ml of 18 proteogenic amino acids, 10 μg/ml Tyr, 40 μg/ml m-Tyr, and no Phe. Error bars represent standard deviation from 3 biological replicates. Download FIG S1, PDF file, 0.1 MB (92KB, pdf) .

Copyright © 2021 Wood et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

FIG S2

Growth curves comparing wild-type PheRS and double mutant pheT G318W/pheS A294G in both a relA+ and ΔrelA background. Cultures were growing in either medium A or medium B, and OD600 was taken every hour for 8 h. Growth curves were performed with MG1655 E. coli relA+ with wild-type PheRS (solid line) and double mutant PheRS, pheS A294G/pheT G318W (dashed lines), in either medium A (green) or medium B (blue) or with ΔrelA E. coli with wild-type PheRS (solid line) and double mutant PheRS (dashed lines) in either medium A (purple) or medium B (orange). Medium A is a supplemented M9 minimal medium that contains 40 μg/ml of all 20 proteogenic amino acids, and medium B is a supplemented M9 minimal medium with 40 μg/ml of 18 proteogenic amino acids, 10 μg/ml Tyr, 40 μg/ml m-Tyr, and no Phe. Error bars represent standard deviation from 3 biological replicates. Download FIG S2, PDF file, 0.1 MB (81.9KB, pdf) .

Copyright © 2021 Wood et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

FIG S3

Disruption of proteome homeostasis represented by volcano plots. Total proteome analysis was performed on wild-type pheS and pheS A294S in either MG1655 relA+ or ΔrelA backgrounds grown in medium B. (A) relA+ pheS A294S versus relA+ wild-type pheS. (B) ΔrelA wild-type pheS versus relA+ wild-type pheS. (C) ΔrelA pheS A294S versus relA+ pheS A294S. (D) ΔrelA pheS A294S versus ΔrelA wild-type pheS. (E) ΔrelA pheS A294S versus relA+ wild-type pheS. Download FIG S3, PDF file, 0.1 MB (155.8KB, pdf) .

Copyright © 2021 Wood et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

TABLE S1

Differentially expressed proteins in ΔrelA WT pheS/pheT versus relA+ WT pheS/pheT grown in medium B. Download Table S1, DOCX file, 1.8 MB (1.9MB, docx) .

Copyright © 2021 Wood et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

TABLE S2

Differentially expressed proteins in ΔrelA pheS A294S versus relA+ WT pheS/pheT grown in medium B. Download Table S2, DOCX file, 1.8 MB (1.8MB, docx) .

Copyright © 2021 Wood et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

DATA SET S1

Total proteome analysis. Changes in protein abundance were monitored for wild-type pheS and pheS A294S in either MG1655 relA+ and ΔrelA backgrounds grown in medium B. Over- and underrepresented proteins are noted. Download Data Set S1, XLSX file, 1.2 MB (1.3MB, xlsx) .

Copyright © 2021 Wood et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

FIG S4

Molecular model of increased deacylated tRNAPhe in the cell. (A) Reaction of active site mutant αA294G PheRS, which has decreased specificity for m-Tyr and Tyr compared to wild-type PheRS. The noncognate amino acid will be efficiently aminoacylated onto tRNAPhe, which will be moved to the editing site where hydrolysis of the misacylated tRNAPhe will occur. Deacylated tRNAPhe and noncognate amino acid will be released from PheRS. (B) Reaction of active site mutant αA294S PheRS, which has increased specificity for m-Tyr and Tyr compared to wild-type PheRS. The noncognate amino acid will not bind and therefore will not be aminoacylated onto tRNAPhe. Download FIG S4, PDF file, 0.1 MB (92.4KB, pdf) .

Copyright © 2021 Wood et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

TEXT S1

Methods and Materials. Download Text S1, DOCX file, 0.02 MB (22.7KB, docx) .

Copyright © 2021 Wood et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.


Articles from mBio are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES